INTERNATIONAL PATENT: TESSERA THERAPEUTICS, INC. FILES APPLICATION FOR "ST1CAS9 COMPOSITIONS AND METHODS FOR MODULATING A GENOME"

GENEVA, Sept. 22 -- TESSERA THERAPEUTICS, INC. (101 South StreetSuite 300Somerville, Massachusetts 02143) filed a patent application (PCT/US2025/020092) for "ST1CAS9 COMPOSITIONS AND METHODS FOR MODULATING A GENOME" on Mar 14, 2025. With publication no. WO/2025/194138, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CARO, Florence (c/o Tessera Therapeutics, Inc.101 South StreetSuite 300Somerville, Massachusetts 02143), CORBETT, Sean (c/o Tessera Therapeutics, Inc.101 South StreetSuite 300Somerville, Massachusetts 02143), ...